1. Home
  2. AVBH vs SLN Comparison

AVBH vs SLN Comparison

Compare AVBH & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBH
  • SLN
  • Stock Information
  • Founded
  • AVBH 2003
  • SLN 1994
  • Country
  • AVBH United States
  • SLN United Kingdom
  • Employees
  • AVBH N/A
  • SLN N/A
  • Industry
  • AVBH
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVBH
  • SLN Health Care
  • Exchange
  • AVBH Nasdaq
  • SLN Nasdaq
  • Market Cap
  • AVBH 282.1M
  • SLN 268.8M
  • IPO Year
  • AVBH N/A
  • SLN N/A
  • Fundamental
  • Price
  • AVBH $25.99
  • SLN $7.30
  • Analyst Decision
  • AVBH Strong Buy
  • SLN Buy
  • Analyst Count
  • AVBH 4
  • SLN 6
  • Target Price
  • AVBH $28.38
  • SLN $39.67
  • AVG Volume (30 Days)
  • AVBH 28.2K
  • SLN 173.3K
  • Earning Date
  • AVBH 10-23-2025
  • SLN 11-13-2025
  • Dividend Yield
  • AVBH N/A
  • SLN N/A
  • EPS Growth
  • AVBH N/A
  • SLN N/A
  • EPS
  • AVBH N/A
  • SLN N/A
  • Revenue
  • AVBH $22,129,000.00
  • SLN $27,169,000.00
  • Revenue This Year
  • AVBH $21.53
  • SLN N/A
  • Revenue Next Year
  • AVBH $17.90
  • SLN N/A
  • P/E Ratio
  • AVBH N/A
  • SLN N/A
  • Revenue Growth
  • AVBH N/A
  • SLN 22.28
  • 52 Week Low
  • AVBH $19.75
  • SLN $1.97
  • 52 Week High
  • AVBH $26.59
  • SLN $18.32
  • Technical
  • Relative Strength Index (RSI)
  • AVBH N/A
  • SLN 68.08
  • Support Level
  • AVBH N/A
  • SLN $6.92
  • Resistance Level
  • AVBH N/A
  • SLN $7.75
  • Average True Range (ATR)
  • AVBH 0.00
  • SLN 0.56
  • MACD
  • AVBH 0.00
  • SLN 0.13
  • Stochastic Oscillator
  • AVBH 0.00
  • SLN 82.88

About AVBH Avidbank Holdings Inc. Common stock

Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: